𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Analysis of S Gene Mutation of the Hepatitis B Virus in Adult Liver Transplant Recipients Showing Resistance to Hepatitis B Immunoglobulin Therapy

✍ Scribed by Park, G.-C.; Hwang, S.; Ahn, C.-S.; Kim, K.-H.; Moon, D.-B.; Ha, T.-Y.; Song, G.-W.; Jung, D.-H.; Shin, Y.W.; Kim, S.-H.; Chang, K.-H.; Namgoong, J.-M.; Park, C.-S.; Park, H.-W.; Park, Y.-H.; Kang, S.-H.; Jung, B.-H.; Lee, S.-G.


Book ID
122158315
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
663 KB
Volume
45
Category
Article
ISSN
0041-1345

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Escape hepatitis B virus mutations in re
✍ Bruno Roche; Anne-Marie Roque-Afonso; Mylene Sebagh; Valerie Delvart; Jean Charl πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 127 KB πŸ‘ 2 views

A variety of prophylactic strategies are used to prevent the risk of hepatitis B virus (HBV) transmission from antibody to hepatitis B core antigen (anti-HBc)-positive donors. The mechanisms underlying the failure of HBV immunoglobulin monoprophylaxis have been poorly evaluated. Seventy-seven anti-H

Emergence of hepatitis B virus S gene mu
✍ Elisabetta Cariani; Antonella Ravaggi; Elisabetta Tanzi; Luisa RomanΓ²; Gianfranc πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 569 KB

## Abstract Immunological and genomic analysis of the β€œa” determinant was carried out in seven patients with concurrent HBsAg and anti‐HBs, four of whom were immunized against hepatitis B virus at liver transplant, two with histologically characterized chronic hepatitis B virus infection, and one H

Incidence and clinical consequences of s
✍ Norah A. Terrault; Shuan Zhou; Robert W. McCory; Timothy L. Pruett; John R. Lake πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 230 KB πŸ‘ 1 views

Mutations in the "a" determinant of the surface gene have been associated with failure of hepatitis B immunoglobulin (HBIg) prophylaxis. We compared sequences from the surface and polymerase regions of hepatitis B virus (HBV) from 4 patients who failed high-dose HBIg therapy with two control groups: